Michael Hudecek

13.0k citations
112 papers · 6.4k · 4 hit papers · h-index 39

Impact in

  • Oncology top 0.2%
    • CAR-T cell therapy research
  • Immunology top 1%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • CAR-T cell therapy research 96
    • Immune Cell Function and Interaction 23
    • Immunotherapy and Immune Responses 18

Michael Hudecek

104 papers receiving 6.3k citations

Michael Hudecek's Hit Papers

The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells 2019 · 379 citations
3790+4+8Years since publication200400600

Peers

Michael Hudecek
Comparison fields: 5 of 112
  • Oncology 5.4k
  • Immunology 2.0k
  • Hematology 677
  • Genetics 1.6k
  • Biomedical Engineering 1.9k
Replace Rosandra N. Kaplan with:
Rosandra N. Kaplan United States
Zhaohui Zheng United States
Joseph A. Fraietta United States
Vanessa Gonzalez United States
Carlos A. Ramos United States
Anne Chew United States
Enli Liu United States
Marco Ruella United States
Bambi Grilley United States
Mohamad Hamieh United States
Michael Hudecek relative to Rosandra N. Kaplan United States Rosandra N. Kaplan's profile →
Citations per field
00.5×3.6×
Rosandra N. Kaplan · 1×
Citations per year

Countries citing papers authored by Michael Hudecek

Since Specialization
Citations

This map shows the geographic impact of Michael Hudecek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hudecek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hudecek more than expected).

Fields of papers citing papers by Michael Hudecek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hudecek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hudecek. The network helps show where Michael Hudecek may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Hudecek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Hudecek Line = papers co-authored together Michael Hudecek links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
Hit paper breakdown →
2016741
2
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
Hit paper breakdown →
2015639
3 2013424
4
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
Hit paper breakdown →
2014406
5
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Hit paper breakdown →
2019379
6 2019238
7 2016222
8 2010210
9 2016194
10 2017184
11 2019154
12 2018153
13 2014139
14 2009113
15 2021113
16 2020113
17 2019111
18 202092
19 201486
20 201079

About Michael Hudecek

Michael Hudecek is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Biomedical Engineering, having authored 112 papers that have together received 6.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (96 papers), Virus-based gene therapy research (30 papers), Immune Cell Function and Interaction (23 papers), Viral Infectious Diseases and Gene Expression in Insects (22 papers), Immunotherapy and Immune Responses (18 papers), Nanowire Synthesis and Applications (17 papers), CRISPR and Genetic Engineering (13 papers) and Multiple Myeloma Research and Treatments (11 papers). The work is most often cited by research in Oncology (5.4k citations), Immunology (2.0k citations), Hematology (677 citations), Genetics (1.6k citations) and Biomedical Engineering (1.9k citations). Michael Hudecek has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Stanley R. Riddell, Daniel Sommermeyer, Hermann Einsele, Paula L. Kosasih, Cameron J. Turtle, Michael C. Jensen, David G. Maloney, Christoph Rader, Tea Gogishvili and Thomas Nerreter. Their work appears in journals such as Blood, Frontiers in Immunology, Journal for ImmunoTherapy of Cancer, Leukemia and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact